Sutura Therapeutics Ltd
Thanuja Gali Ramamoorthy is a Senior Scientist at Sutura Therapeutics Ltd. Thanuja previously worked as a Postdoctoral Research Associate at The University of Manchester, focusing on circadian clock control of pulmonary inflammation and epigenetic programming. With a background in molecular and cellular biology, Thanuja conducted research on skeletal muscle metabolism and chromatin modifications during their PhD and earlier research assistant positions. Thanuja is skilled in in vivo expertise, tissue-specific gene targeting, and in vitro histone modification assays.
Sutura Therapeutics Ltd
Sutura Therapeutics is a biopharmaceutical company at the forefront of developing next-generation biomolecular medicines. Through its innovative drug conjugate platform, Sutura is advancing the field of biomolecular medicine to address the unmet medical needs of patients with diseases which were previously considered undruggable. Biomolecule-based medicines have unique biological properties and actions, which make them promising in treating diseases. However, the size and shape of biomolecules often limit their capacity to enter cells and reach their target, making them less effective. Sutura’s drug conjugates platform is designed to overcome these limitations and has the potential to address a broad range of indications.